TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 66 filers reported holding TERNS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,417,341 | -38.5% | 878,199 | +7.0% | 0.00% | – |
| Q2 2023 | $7,181,318 | +409.5% | 820,722 | +589.5% | 0.00% | – |
| Q1 2023 | $1,409,422 | +16.3% | 119,039 | -0.0% | 0.00% | – |
| Q4 2022 | $1,212,174 | +388.8% | 119,074 | +183.3% | 0.00% | – |
| Q3 2022 | $248,000 | +406.1% | 42,037 | +111.9% | 0.00% | – |
| Q2 2022 | $49,000 | -89.9% | 19,837 | -87.8% | 0.00% | – |
| Q1 2022 | $485,000 | -57.6% | 163,237 | +0.8% | 0.00% | – |
| Q4 2021 | $1,145,000 | -26.9% | 162,019 | +7.8% | 0.00% | – |
| Q3 2021 | $1,567,000 | -0.7% | 150,340 | +16.8% | 0.00% | – |
| Q2 2021 | $1,578,000 | -27.3% | 128,703 | +30.5% | 0.00% | – |
| Q1 2021 | $2,170,000 | – | 98,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,099,309 | $13,015,819 | 9.59% |
| VR Adviser, LLC | 3,619,522 | $42,855,140 | 8.37% |
| Vivo Capital, LLC | 6,657,992 | $78,830,625 | 5.47% |
| Fairmount Funds Management LLC | 2,040,000 | $24,153,600 | 4.15% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $8,457,134 | 3.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 667,922 | $7,908,196 | 3.26% |
| Ikarian Capital, LLC | 721,341 | $8,540,677 | 1.94% |
| Orbimed Advisors | 7,619,135 | $90,210,558 | 1.77% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 | $40,827,576 | 1.72% |
| CROSSPOINT FINANCIAL, LLC | 12,054 | $142,719 | 1.54% |